A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients who Initiated Exenatide as Compared with those who Initiated Other non-Glucagon-Like Peptide 1 Receptor Agonists based Glucose Lowering Drugs (EXCEED)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Clinical Practice Research Datalink

  Sweden National Prescribed Drugs Register / Läkemedelsregistret

  The Information System for Research in Primary Care (SIDIAP)

  Sweden National Prescribed Drugs Register / Läkemedelsregistret

  The Information System for Research in Primary Care (SIDIAP)

  The Norwegian Prescribed Drug Registry
• Data source(s), other:
  Drugs and Pregnancy Finland, eDRIS
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Disease registry

  Drug dispensing/prescription data

  Electronic healthcare records (EHR)

  Other
• Data sources (types), other:
  Prescription event monitoring

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No